Decreased recovery of CD4 lymphocytes in older HIV-infected patients beginning highly active antiretroviral therapy
- 1 August 2001
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 15 (12) , 1576-1579
- https://doi.org/10.1097/00002030-200108170-00017
Abstract
Among virological responders, the area under the curve of the CD4 count minus baseline (AUCMB) after 3, 9, 15 and 18 months of highly active antiretroviral therapy (HAART) was less in individuals 55 years or older (P < 0.05). Fewer older individuals achieved increases of 50, 100, or over 150 CD4 cells/l. A random quadratic time course model estimated that the AUCMB decreased 35 cells/year for each 10 years of additional age during the first 12 months after HAART (P < 0.005).Keywords
This publication has 15 references indexed in Scilit:
- Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increaseAIDS, 2000
- Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort StudyThe Lancet, 2000
- Both Serum HIV Type 1 RNA Levels and CD4+Lymphocyte Counts Predict Clinical Outcome in HIV Type 1-Infected Subjects with 200 to 500 CD4+Cells per Cubic MillimeterAIDS Research and Human Retroviruses, 2000
- The Role of the Thymus in Immune Reconstitution in Aging, Bone Marrow Transplantation, and HIV-1 InfectionAnnual Review of Immunology, 2000
- Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitorAIDS, 2000
- Determinants of sustainable CD4 lymphocyte count increases in response to antiretroviral therapyAIDS, 1999
- Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimenAIDS, 1999
- Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort studyThe Lancet, 1999
- Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 diseaseThe Lancet, 1998
- Age, Thymopoiesis, and CD4+ T-Lymphocyte Regeneration after Intensive ChemotherapyNew England Journal of Medicine, 1995